The Interview
Deal Maker of the Year Awards 2012
John C. K Managing Director at Iro
Cereplast raises $5m from Ironridge Global Partners
John C. Kirkland has handled several hundred billion dollars in public offerings and private placements of debt and equity securities for clients such as Goldman Sachs, SunAmerica, and Boeing Capital. As a practicing securities attorney for over 20 years, he represented bulge bracket investment banks, venture capital and private equity firms, and numerous public companies. Kirkland is a preeminent expert in the small cap equities market, and is known for developing unique and innovative public company financing structures.
John Kirkland currently serves as Managing Director of Ironridge Global Partners. He was most recently partner in charge of the securities group at Luce Forward (now McKenna Long & Aldridge), was previously partner in charge of the securities practice at the Los Angeles office of Greenberg Traurig, and began his legal career at Cadwalader Wickersham & Taft.
Kirkland is the author of “Practical Approaches to Securities Compliance Issues,” SEC Compliance Best Practices (Thomson Reuters 2010 ed.), and various articles oncorporate and securities topics. He has been repeatedly listed in Who’s Who in American Law and Southern California Super Lawyers, and quoted in publications such as the Wall Street Journal, Los Angeles Business Journal, and New York Times.
John Kirkland received his BA in Biology-Psychology from Columbia University, and his JD from UCLA School of Law.
Q 26
Can you give an overview of Ironridge Global and its
organisational structure? Ironridge Global Partners, LLC is an
www.finance-monthly.com
institutional investor making direct equity investments in small cap public companies. We have entered into some forty financing transactions since last year, ranging in size from a quarter million to US $10 million each, and have never shorted a single share of any company’s stock. We remain a common stockholder of every company we have invested in since inception.
Ironridge Global assists public companies in financing operations and expansion by supplying innovative funding solutions and flexible capital. We seek to unlock the full potential of cash- constrained businesses, propelling higher growth and more profitable enterprises.
Ironridge takes a tailored approach to understanding smaller companies and their unique financial situation, needs and goals. We have unbridled flexibility to create innovative and mutually beneficial financial structures, and develop individual solutions appropriate to current company and market conditions.
Q
What are the main areas of Ironridge’s expertise?
Although we view ourselves as industry agnostic, we always look for companies that we believe have significant growth potential. Ironridge has several investment divisions, each focusing on specific industry sectors.
Ironridge BioPharma specializes in equity investments in life sciences, including biotechnology, pharmaceutical, nutraceutical, medical device and enabling technology companies. Our investments include exploration and development of oil and gas reserves, integrated power firms, cleantech and alternative
energy suppliers. Ironridge Media focuses on entertainment and media ventures, such as production and digital distribution, while Ironridge China invests in Chinese public companies.
Ironridge Products finances
business and consumer product development, transportation and commercialization, and Ironridge Technology invests in stocks related to researching, developing and creating technology, such as computer software and hardware, electronics, information technology systems and services.
Our broad industry experience and high-level expertise enables us to structure flexible financial solutions appropriate for each individual situation.
Q
Does Ironridge have any unique financing structures?
Ironridge Global’s Liability for Equity (LIFE) program allows small cap public companies to satisfy trade payables, debts and other liabilities in exchange for unregistered common stock. We are the industry leader in this innovative financing structure, which substantially reduces the transactional costs and time necessary to complete a financing. No registration statement is required, and there are no registration rights.
Issuers can use a LIFE exchange to clean up their balance sheet, by converting short and long-term debt to equity. This allows them to repurpose their resources away from paying existing obligations and toward funding future growth.
LIFE transactions are most typically used to pay off outstanding accounts payable owed to service
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126